France Structural Heart Imaging Market Size, Share, and COVID-19 Impact Analysis, By Modality (Echocardiogram, MRI, Nuclear Imaging, CT, Angiogram, and Others), By Application (Diagnostic Imaging and Interventional Cardiology), By Procedure (Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral Valve Repair (TMVR), Transcatheter Aortic Valve Replacement (TAVR), Tricuspid Valve Replacement and Repair, Valvuloplasty, and Others), and France Structural Heart Imaging Market Insights, Industry Trend, Forecasts to 2035

France Structural Heart Imaging Market Size Insights Forecasts To 2035

• The France Structural Heart Imaging Market Size Was Estimated At USD 420.4 Million In 2024
• The France Structural Heart Imaging Market Size Is Expected To Grow At A CAGR Of Around 6.6% From 2025 To 2035
• The France Structural Heart Imaging Market Size Is Expected To Reach USD 849.28 Million By 2035

According to a research report published by Spherical Insights & Consulting, the France Structural Heart Imaging Market size is anticipated to reach USD 849.28 million by 2035, growing at a CAGR of 6.6% from 2025 to 2035. The France structural heart imaging market is driven by the rising prevalence of cardiovascular diseases such as valve disorders and heart failure, along with increasing demand for minimally invasive cardiac procedures. Technological advancements in echocardiography, CT, and MRI imaging, supported by a strong healthcare infrastructure, further fuel market growth.

Market Overview

The France structural heart imaging market size refers to the sector focused on the use of advanced imaging technologies to diagnose, monitor, and guide the treatment of structural heart diseases, including valve disorders, septal defects, and congenital or acquired heart abnormalities. It includes modalities such as echocardiography (2D and 3D), cardiac CT, MRI, and fluoroscopy-based imaging systems used in hospitals, cardiac care centers, and specialized clinics to provide accurate visualization of heart structures, support interventional procedures, and improve patient outcomes.

France’s adoption of the structural heart imaging market size is driven by the country’s significant burden of cardiovascular diseases (CVDs), which remain the leading cause of mortality. According to the French National Institute of Health and Medical Research (INSERM), nearly 150,000 new cases of heart failure are diagnosed annually, and valvular heart diseases affect over 10% of adults above 65 years. Increasing prevalence of congenital and acquired structural heart conditions, coupled with the aging population (with approximately 20% aged 65 and above in 2024), underscores the need for accurate and minimally invasive diagnostic and interventional imaging solutions. Rising awareness of early detection and preventive cardiology further fuels the demand for advanced structural heart imaging systems across hospitals and specialized cardiac centers.

Government support reinforces this market size. The French Ministry of Health and agencies like INSERM and CNRS fund research and development in cardiovascular imaging and interventional cardiology, with annual allocations exceeding €50 million for innovative imaging technologies, minimally invasive procedures, and clinical trials.

Report Coverage

This research report categorizes the market size for the France structural heart imaging market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France structural heart imaging market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France structural heart imaging market.

Driving Factor

The France structural heart imaging market size is driven by the rising prevalence of cardiovascular diseases, an aging population, and growing demand for minimally invasive interventions. Technological advancements in 3D echocardiography, CT, and MRI, along with government support and awareness of early diagnosis, further boost market growth.

Restraining Factors

The France structural heart imaging market size is restrained by the high cost of advanced imaging equipment, limited reimbursement for certain procedures, and the need for highly trained specialists to operate complex imaging systems. Additionally, stringent regulatory requirements and maintenance expenses can slow adoption in smaller clinics.

Market Segmentation

The France structural heart imaging market share is classified into modality, application, and procedure.

• The angiogram segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France structural heart imaging market size is segmented by modality into echocardiogram, MRI, nuclear imaging, CT, angiogram, and others. Among these, the angiogram segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The angiogram segment is growing because of its critical role in diagnosing and guiding treatment for coronary artery disease, valvular disorders, and other structural heart conditions. Its high accuracy, real-time imaging capabilities, and essential use in minimally invasive interventions drive strong adoption in hospitals across France.

• The interventional cardiology segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.

The France structural heart imaging market size is segmented by application into diagnostic imaging and interventional cardiology. Among these, the interventional cardiology segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. The interventional cardiology segment is growing because of the increasing adoption of minimally invasive procedures, such as transcatheter valve repair and replacement, which require precise imaging guidance. The rising prevalence of structural heart diseases and demand for safer, faster recovery treatments drive strong market growth in France.

• The transcatheter aortic valve replacement (TAVR) segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France structural heart imaging market size is segmented by procedure into surgical aortic valve replacement (SAVR), transcatheter mitral valve repair (TMVR), transcatheter aortic valve replacement (TAVR), tricuspid valve replacement and repair, valvuloplasty, and others. Among these, the transcatheter aortic valve replacement (TAVR) segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The transcatheter aortic valve replacement (TAVR) segment is growing because of its minimally invasive approach, shorter recovery time, and reduced procedural risks compared to traditional surgery. Increasing cases of aortic stenosis among the aging population and rising adoption of TAVR procedures in France’s hospitals drive strong market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France structural heart imaging market size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GE Healthcare
• Siemens Healthineers
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• FUJIFILM Holdings Corporation
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Medtronic plc
• Bracco Imaging S.p.A.
• Hitachi Ltd
• Abbott Laboratories
• Samsung Medison Co., Ltd.
• Mindray Medical International Limited
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France structural heart imaging market based on the below-mentioned segments:

France Structural Heart Imaging Market, By Modality

• Echocardiogram
• MRI
• Nuclear Imaging
• CT
• Angiogram
• Others

France Structural Heart Imaging Market, By Application

• Diagnostic Imaging
• Interventional Cardiology

France Structural Heart Imaging Market, By Procedure

• Surgical Aortic Valve Replacement (SAVR)
• Transcatheter Mitral Valve Repair (TMVR)
• Transcatheter Aortic Valve Replacement (TAVR)
• Tricuspid Valve Replacement and Repair
• Valvuloplasty
• Others